AusperBio Raises $73M in Series B to Advance Chronic Hepatitis B Cure
January 3, 2025
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure